At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 102 enrolled
Drug / intervention
Vitamin D3 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Blinded Exploratory Randomized Controlled Trial (RCT) to Determine Optimal Vitamin D3 Supplementation Strategies for Acute Fracture Healing
In Brief
A Phase 2 clinical trial evaluating Vitamin D3 and Placebo for Fracture. Completed, enrolled 102 participants across 2 sites in 2 countries.
Detailed Summary
The objective is to determine the effect of vitamin D3 supplementation on fracture healing at 3 months.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFracture
CountriesCanada, United States
CollaboratorsMcMaster University
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartNov 2016
Primary CompletionAug 2019
Study CompletionDec 2021
TodayJul 2026
First PostedJun 1, 2016
Enrollment StartNov 21, 2016
Primary CompletionAug 1, 2019
Study CompletionDec 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 10.1 years ago
Interventions
Vitamin D3drug
Placeboother